Literatur
-
1
Altmann K C, Shaw L J, Hachamovitch R. et al .
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta analysis.
JACC.
2002;
39
1151-1158
-
2
Baer F M, Theissen P, Crnac J. et al .
Head to head comparison of dobutamine-transesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease.
Eur Heart J.
2000;
21
981-991
-
3
Baer F M, Voth E, Schneider C A. et al .
Dobutamine-gradient echo MRI: a functional and morphologic approach to the detection of residual myocardial viability.
Circulation.
1995;
91
1006-1015
-
4
Braunwald E, Kloner R A.
The stunned myocardium: Prolonged, postischemic ventricular dysfunction.
Circulation.
1982;
66
1146-1149
-
5
Cleland J GF, Pennell D J, Ray S G. et al .
Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure (CHRISTMAS trial).
Lancet.
2003;
362
14-21
-
6
Hoffer E P, Dewe W, Celentano C. et al .
Low-level exercise echocardiography detects contractile reserve and predicts reversible dysfunction after acute myocardial infarction.
J Am Coll Cardiol.
1999;
34
989-997
-
7
Kim J R, Fieno D S, Parrish T B. et al .
Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function.
Circulation.
1999;
100
1992-2002
-
8
Knuesel R P, Nanz D, Wyss C. et al .
Characterization of Dysfunctional Myocardium by Positron Emission Tomography and Magnetic Resonance: Relation to Functional Outcome After Revascularization.
Circulation.
2003;
108
1095-1100
-
9
Mahrholdt H, Wagner A, Holly T A. et al .
Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging.
Circulation.
2002;
106
2322-2327
-
10
Nesto R W, Cohn L H, Collins J J. et al .
Inotropic contractile reserve: a useful predictor of increased 5-year survival and improved postoperative left ventricular function in patients with coronary artery disease and reduced ejection fraction.
Am J Cardiol.
1982;
50
39-44
-
11 Nixdorff U. Vitalitätsdiagnostik. Thieme 2002 In: Flachskampf FA, Hrsg.. Praxis der Echokardiographie 2002: 204-216
-
12
Rahimtoola S H.
The hibernating myocardium.
Am Heart J.
1989;
117
211-221
-
13
Rasmussen S, Corya B, Feigenbaum H, Knoebel S.
Detection of myocardial scar tissue by M-mode echocardiography.
Circulation.
1978;
57
230-238
-
14
Sawada S.
Dobutamine echocardiography for detection of viable myocardium in ischemic cardiomyopathy.
Echocardiography.
2000;
27
69-77
-
15
Schelbert H R.
Merits and limitations of radionuclide approaches to viability and future developments.
J Nucl Cardiol.
1994;
1
86-96
-
16
Tillisch J, Brunken R, Marshall R. et al .
Reversibility of cardiac wall motion abnormalities predicted by positron tomography.
N Eng J Med.
1986;
314
884-888
-
17
Vom Dahl J, Altehoefer C, Sheehan H. et al .
Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and Fluorine-18-FDG PET on clinical outcome in coronary artery disease.
J Nucl Med.
1997;
38
742-748
-
18
Kim R J, Wu E, Rafael A. et al .
The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction.
N Eng J Med.
2000;
343
1445-1453
1 Mit „→“ sind Textstellen gekennzeichnet, zu denen Sie zusätzliche Texte im Internet unter www.thieme.de/dmw/cme finden können.
Prof. Dr. Frank M. Baer
Klinik III für Innere Medizin, Universität zu Köln
Joseph-Stelzmann-Straße 9
50924 Köln
Phone: 0221/4786202
Fax: 0221/4786651
Email: Frank.Baer@Uni-Koeln.de
